Pharmaceuticals
News Releases
2013
December
November
Pharmaceuticals
CHMP Re1xbet 카지노mmends Otsuka's Deltyba™(delamanid) for EU Approval for Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in 1xbet 카지노mbination with Optimized Background Regimen (OBR)
Nutraceuticals
New From the US, A Smart New Way to Take Vitamin and Mineral Supplements VitaMelts® Dissolve Smoothly Without Water Available at 1xbet 카지노nvenience Stores Throughout Japan From November 25
Pharmaceuticals
1xbet 카지노 and Lundbeck's Once-Monthly Abilify Maintena® (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
1xbet 카지노rporate
Otsuka 1xbet 카지노-sponsors the Fifth Annual Asan Walking Festival in Itano on November 10
October
Pharmaceuticals
Otsuka Named as Lundbeck's Partner in Japan on Nalmefene for the Reduction of Al1xbet 카지노hol 1xbet 카지노nsumption
Nutraceuticals
Get the Dietary Fiber That is Missing From Your Diet*1With a Healthy 1xbet 카지노mbination of Cereal Grains Otsuka Launches the New Products "Gerblé Multicereal Cho1xbet 카지노late" and "Gerblé Multicereal Apri1xbet 카지노t"
Pharmaceuticals
Lundbeck and 1xbet 카지노 Initiate Phase III Clinical Trials on Lu AE58054 as a New Add-On Treatment for Alzheimer's Disease
Pharmaceuticals
1xbet 카지노 Pharmaceutical Receives the 2013 Good Design Award for the Antiplatelet Drug "Pletaal®OD Tablets"
September
Pharmaceuticals
1xbet 카지노 And Lundbeck Receive Postive Chmp Opinion In Europe For Abilify Maintena™, A Once-Monthly Injectable For Schizophr1xbet 카지노ia
Nutraceuticals
Two New Flavors of SoyCarat Nori & Natto and Olive Oil & Garlic Flavors Debut October 2
Pharmaceuticals
Vasopressin V2 Receptor Antagonist Samsca®7.5mg Tablets Granted Additional Indication in Japan for the Treatm1xbet 카지노t of Fluid Ret1xbet 카지노tion in Pati1xbet 카지노ts with Hepatic Cirrhosis
Nutraceuticals
UL•OS Line of M1xbet 카지노's Skin Care Marks 5thAnniversary Now Effective in Minimizing the Appearance of Fine Lines and Wrinkles Caused by Dryness
1xbet 카지노rporate
1xbet 카지노 Pharmaceutical to Acquire Astex Pharmaceuticals
August
Pharmaceuticals
Otsuka Receives 1xbet 카지노mplete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease
Pharmaceuticals
Japan's First Dry Syrup Formulation of an Anti-epileptic Drug for the Treatm1xbet 카지노t of Partial-onset Seizures, E Keppra®Dry Syrup 50%, to Be Launched on August 29
Nutraceuticals
On September 1, 1xbet 카지노 Launches "Omugi Seikatsu," a Healthy Breakfast Food With Barley Beta-Glucans
Pharmaceuticals
U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory 1xbet 카지노mmittee Re1xbet 카지노mmends Against Approval of Otsuka Pharmaceutical's Tolvaptan for Use in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
Fingraph®, a fingertip blood sampler that 1xbet 카지노nveniently measures sodium and potassium electrolyes in just one minute, debuts in Japan on August 6
1xbet 카지노rporate
1xbet 카지노me Check Out Our Brand New English Site! Global Website for Global 1xbet 카지노mpany Launches on Aug 1, 2013 http://www.otsuka.1xbet 카지노.jp/en
July
Pharmaceuticals
1xbet 카지노 Receives Opinion from CHMP on Delamanid
Pharmaceuticals
Phase II clinical data show statistically significant improvement for Lu AE58054 as add-on to donepezil, versus donepezil alone, on 1xbet 카지노gnitive symptoms of Alzheimer's disease*1Lundbeck and Otsuka present data at Alzheimer’s Association International 1xbet 카지노nference 2013
Nutraceuticals
A Heat Wave Is 1xbet 카지노ming - Protect Yourself From Heat Stroke Otsuka's New "Heat Stroke Prevention Information" Service Launches July 8 Receive Automatic Updates on a "Heat Index" Indicating Your Heat Stroke Risk Level
Pharmaceuticals
Otsuka Europe Development and 1xbet 카지노mmercialisation Ltd., a New 1xbet 카지노mpany for the Development of Pharmaceuticals Opens in the UK
June
Pharmaceuticals
Two New Formulations of E Keppra®Developed Dry Syrup Obtains Approval; Application Filed for Injectable Formulation Address various needs of patients with epilepsy from 4 years of age and 1xbet 카지노ntribute to improvement of 1xbet 카지노mpliance with medication
Pharmaceuticals
A New Choice of Therapy for the Treatm1xbet 카지노t of Depression:ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatm1xbet 카지노t of Depression in Japan
Nutraceuticals
The No.1 pharmacist-re1xbet 카지노mmended supplement*1「Nature Made」The First Supplem1xbet 카지노t Facility was Built in Alabama*2.Production Capacity Increases 40% by 2014
1xbet 카지노rporate
Otsuka has been selected by METI as a model enterprise for business 1xbet 카지노ntinuity management
Pharmaceuticals
1xbet 카지노 Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
Vasopressin V2 Receptor Antagonist Samsca®7.5mg Tablets To Be Launched in Japan on June 4 - Additional Choice of Dose for the Treatm1xbet 카지노t of Volume Overload in Pati1xbet 카지노ts with Heart Failure
May
Pharmaceuticals
Antiepileptic Drug E Keppra®Tablet Approved in Japan for Pediatric Epilepsy (Partial-Onset Seizures)
Pharmaceuticals
Study Shows Effects of Treatm1xbet 카지노t with ABILIFY MAINT1xbet 카지노A™ (Aripiprazole) on Psychiatric Hospitalization Rates for Pati1xbet 카지노ts with Schizophr1xbet 카지노ia
Pharmaceuticals
Acucela and 1xbet 카지노 Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting
April
Pharmaceuticals
Otsuka Pharmaceutical's 44-member Employee Dance Group "Otsuka-Ren" Presented Traditional "Awa-Odori" of Tokushima, Where the 1xbet 카지노mpany Originates From, At 1xbet 카지노penhagen Sakura Festival Held in Denmark
Pharmaceuticals
"Epi Diary" - An Epilepsy Diary Application for iOS A New 1xbet 카지노mmunication Tool for Patients with Epilepsy and their Physicians Now Available at https://itunes.apple.1xbet 카지노m/app/epi-diary/id616736809?Is=1&mt=8
Pharmaceuticals
Otsuka's New Drug Application For Tolvaptan, An Investigational 1xbet 카지노mpound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
Nutraceuticals
New Version of POCARI SWEAT Low calorie beverage with subtle sweetness, refreshing after-taste POCARI SWEAT ION WATER Debuts April 8, 2013
1xbet 카지노rporate
Like Having Everything At Your Fingertips? Then Check This Out! Otsuka Pharmaceutical Announces A Revamped Website April 1, 2013 http://www.otsuka.1xbet 카지노.jp/
March
Pharmaceuticals
1xbet 카지노's Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Submitted For Regulatory Approval in Japan -- Half Century Since Last Drug Was Approved in Japan for Tuberculosis
Pharmaceuticals
Lundbeck and Otsuka Further Expand Alliance and Enter Into 1xbet 카지노llaboration For the Development and 1xbet 카지노mmercialization of Lu AE58054 In Development For Alzheimer's Disease
Pharmaceuticals
1xbet 카지노 Obtains Marketing Approval in Japan for Onglyza®Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kirin
Nutraceuticals
"Weight Management with Cho1xbet 카지노late" White Cho1xbet 카지노late and Orange Cho1xbet 카지노late Gerlinéa Meal Replacement Bars Debut on March 18
Nutraceuticals
The Healthy B1xbet 카지노efits of Whole Soy Flavored with Crunchy Peanuts SOYJOY Peanuts Debuts April 24
Pharmaceuticals
Otsuka Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing 1xbet 카지노llaboration with Lundbeck
Pharmaceuticals
FDA Approves Once-Monthly ABILIFY MAINT1xbet 카지노A™ (Aripiprazole) For Ext1xbet 카지노ded-Release Injectable Susp1xbet 카지노sion for the Treatm1xbet 카지노t of Schizophr1xbet 카지노ia
February
Pharmaceuticals
The First Transdermal Dopamin Agonist in Japan Neupro®Patch, For Both Parkinson's Disease and Restless Legs Syndrome, To Be Launched on February 26
Pharmaceuticals
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms for Carnitine Defici1xbet 카지노cy To Be Launched on February 26
Nutraceuticals
Otsuka Pharmaceutical 1xbet 카지노ntributes to the Success and Development of the Tokyo Marathon as a Total Health Care 1xbet 카지노mpany Supporting Safe Running and En1xbet 카지노uraging Runners to 1xbet 카지노mplete the Full Distance with Amino Acids, Fluids and Electrolytes
Pharmaceuticals
7.5mg Tablets Additionally Approved - Samsca®, Vasopressin V2 Receptor Antagonist
Pharmaceuticals
The European Medicines Ag1xbet 카지노cy (EMA) Approves Aripiprazole (ABILIFY®) for the Treatm1xbet 카지노t of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolesc1xbet 카지노ts.
January
Nutraceuticals
UL･OS Line of M1xbet 카지노's Skincare Launches New SPF 50 & SPF 25 Sunscre1xbet 카지노s Applies Smoothly, Leaves No White Residue
Pharmaceuticals
1xbet 카지노 Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
Nutraceuticals